Biallelic Loss‐Of‐Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency
Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)
DOI: 10.1002/jimd.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 05.07.2026. Verfasst von Pranavi Hegde und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Loss of Function Mutation, Mitochondrial Diseases, Mitochondrial Proton-Translocating ATPases, Oxidative Phosphorylation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DBT/Wellcome Trust India Alliance for the study, "Centre for Rare Disease Diagnosis, Research and Training", Department of Health Research for the study, "Delineating the genomic basis of neurodegeneration and mitochondrial disorders associated with defective DNA brea….
Abstract (Originalsprache)
ATP synthase (complex V) catalyzes ATP synthesis and is composed of the F 1 catalytic sector and the F 0 proton‐conducting sector. The e subunit of the F 0 sector, encoded by ATP5ME , is essential for complex V dimerization and cristae organization; however, genetic variants in ATP5ME have not yet been implicated in human disease. We ascertained a 4‐year‐old male, born of a consanguineous marriage, who presented with neuroregression, feeding difficulty, spasticity, encephalopathy, bilateral sensorineural hearing loss and optic atrophy. Exome sequencing identified a biallelic 62 bp deletion, c.‐48_14del in ATP5ME (NM_007100.4; NC_000004.12: g.674234_674295del), spanning the upstream sequence, the 5′ untranslated region, and part of exon 1. Patient‐derived fibroblasts exhibited markedly decreased ATP5ME transcript and protein levels, accompanied by a reduction in the expression of complex I, IV, and V subunits. In vitro assays demonstrated reduced activities of complexes I, IV, and V, impaired mitochondrial respiration, reduced reactive oxygen species levels, decreased mitochondrial membrane potential, and reduced ATP levels. Additionally, atp5me knockout zebrafish demonstrated a severe developmental phenotype characterized by craniofacial defects, reduced locomotion, and decreased ATP levels. This was accompanied by reduced protein levels of complex II and IV subunits, mild decrease in mtDNA, and upregulation of genes associated with glycolysis and oxidative stress. All observed phenotypes were rescued by human ATP5ME mRNA complementation, thereby validating the pathogenicity of ATP5ME deficiency in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
- Department of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
- Center for Innovation in Molecular and Pharmaceutical Sciences, Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, India.
- Bai Jerbai Wadia Hospital for Children, Mumbai, India.
- Department of Radiology, NMC Royal Hospital, Dubai Investment Park, Dubai, UAE.
- Center for Rare Disease Models, Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Hyderabad, India.
ORCID-Profile: Aakanksha Anand, Purvi Majethia, Aarti Sevilimedu, Sanjiban Chakrabarty, Anju Shukla
Förderung
- DBT/Wellcome Trust India Alliance for the study, "Centre for Rare Disease Diagnosis, Research and Training"
- Department of Health Research for the study, "Delineating the genomic basis of neurodegeneration and mitochondrial disorders associated with defective DNA brea…
Zitieren
APA
Hegde, P., Anand, A., Rani, R., Kaur, N., Shah, A., Kulkarni, S., Mallavaram, J. S., Medishetti, R., Kandettu, A., Shaikh, H., Siddiqui, S., Majethia, P., Bhat, V., Radhakrishnan, P., Sevilimedu, A., Chakrabarty, S., & Shukla, A. (2026). Biallelic Loss‐Of‐Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70222
Vancouver
Hegde P, Anand A, Rani R, Kaur N, Shah A, Kulkarni S, et al. Biallelic Loss‐Of‐Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70222
BibTeX
@article{Hegde2026,
author = {Hegde, Pranavi and Anand, Aakanksha and Rani, Rita and Kaur, Namanpreet and Shah, Ami and Kulkarni, Shilpa and Mallavaram, Janani Supraja and Medishetti, Raghavender and Kandettu, Amoolya and Shaikh, Huzail and Siddiqui, Shahyan and Majethia, Purvi and Bhat, Vivekananda and Radhakrishnan, Periyasamy and Sevilimedu, Aarti and Chakrabarty, Sanjiban and Shukla, Anju},
title = {Biallelic Loss‐Of‐Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {4},
doi = {10.1002/jimd.70222}
}
EUVIMED